Corvus Pharmaceuticals (CRVS) Q3 2023 Earnings

Nov 7Confirmed
Nov 2022
Q1 2023
Q2 2023
Q3 2023
-0.32
-0.25
-0.19
-0.12

Details

Expected EPS
-0.12
Actual EPS
-0.12
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Corvus Pharmaceuticals⁩ (⁦CRVS⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts